Search
Nimbus Therapeutics CEO Jeb Keiper on the company's HPK1 data at #ASCO24
- blonca9
- Jun 1, 2024
- 1 min read
Jeb Keiper describes the HKP1 pathway and why he believes his company's expertise in precision engineering and machine learning has helped it discover and develop this asset.